4-amino-3-hydroxybenzoic acid has been researched along with salicylaldehyde in 1 studies
Studies (4-amino-3-hydroxybenzoic acid) | Trials (4-amino-3-hydroxybenzoic acid) | Recent Studies (post-2010) (4-amino-3-hydroxybenzoic acid) | Studies (salicylaldehyde) | Trials (salicylaldehyde) | Recent Studies (post-2010) (salicylaldehyde) |
---|---|---|---|---|---|
8 | 0 | 3 | 377 | 0 | 228 |
Protein | Taxonomy | 4-amino-3-hydroxybenzoic acid (IC50) | salicylaldehyde (IC50) |
---|---|---|---|
Transcription intermediary factor 1-alpha | Homo sapiens (human) | 0.2213 | |
E3 ubiquitin-protein ligase TRIM33 | Homo sapiens (human) | 0.2994 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, L; Luo, WC; Xiao, T; Xie, XY; Xue, CB; Zhang, L | 1 |
1 other study(ies) available for 4-amino-3-hydroxybenzoic acid and salicylaldehyde
Article | Year |
---|---|
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
Topics: Benzaldehydes; Benzoic Acid; Enzyme Inhibitors; Hydrogen Bonding; Models, Molecular; Monophenol Monooxygenase; Quantitative Structure-Activity Relationship; Thiosemicarbazones | 2007 |